| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0087 | 0.9 |